Fondaparinux versus regional citrate anticoagulation in artificial liver support for patients with liver failure and high bleeding risk: A pilot randomized controlled trial
Publication date: December 2026 Source: Transfusion and Apheresis Science, Volume 65, Issue 6 Author(s): Lanzhen Zeng, Ye Lin, Wenfeng Ye, Qinglan Li, Yuanyuan Tu
Fondaparinux versus regional citrate anticoagulation in artificial liver support for patients with liver failure and high bleeding risk: A pilot randomized controlled trial. // Transfusion and Apheresis Science. – URL: https://www.sciencedirect.com/science/article/pii/S1473050226001631?dgcid=rss_sd_all
Fondaparinux versus regional citrate anticoagulation in artificial liver support for patients with liver failure and high bleeding risk: A pilot randomized controlled trial. Transfusion and Apheresis Science. https://www.sciencedirect.com/science/article/pii/S1473050226001631?dgcid=rss_sd_all
“Fondaparinux versus regional citrate anticoagulation in artificial liver support for patients with liver failure and high bleeding risk: A pilot randomized controlled trial.” Transfusion and Apheresis Science.
@article{article69893,
title = {Fondaparinux versus regional citrate anticoagulation in artificial liver support for patients with liver failure and high bleeding risk: A pilot randomized controlled trial},
journal = {Transfusion and Apheresis Science},
url = {https://www.sciencedirect.com/science/article/pii/S1473050226001631?dgcid=rss_sd_all}
}